Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A free microneedling accessory is included with the serum
Most of the evidence giving rise to this claim comes from a few observational studies
Last reviewed: April 21, 2026 Updated with Phase 3 TRIUMPH-4 data Primary sources: NEJM, Eli Lilly, ClinicalTrials.gov Retatrutide is a triple agonist (GLP-1 + GIP + glucagon) currently in Phase 3 trials, showing stronger early weight loss data
Protein is not just about looking good after weight loss
However, during clinical translation, the structural complexity of the human liver, the heterogeneity of disease microenvironments, and interspecies differences often lead to suboptimal performance of nanodrugs in human trials despite promising results in preclinical animal studies
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
